tirzepatide surmount-1 weight loss percent 72 weeks results for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide leads to weight reduction

Currently on semaglutide, liraglutide, or another GLP-1 and not seeing the results you hoped for

Final Thoughts GLP-1 medications have transformed how we treat obesity: Semaglutide broke ground with ~15% average weight loss

Those exploring peptides for weight loss may find it helpful to compare various options, particularly in terms of mechanism, cost, and aesthetic impact

Managing side effects proactively separates people who complete 12 months of treatment from those who discontinue early

Furthermore, Tirzepatide, administered once weekly at 15 mg, proved to be more effective than Semaglutide, administered once weekly at 1 mg, in reducing HbA1c levels